169 related articles for article (PubMed ID: 34978588)
1. N-Glycomic profiling reveals dysregulated glycans related to oral cancer using MALDI-MS.
Wu Y; Liu Y; Shang Z; Liu X; Xu Y; Liu W
Anal Bioanal Chem; 2022 Feb; 414(5):1881-1890. PubMed ID: 34978588
[TBL] [Abstract][Full Text] [Related]
2. Comparing MALDI-MS, RP-LC-MALDI-MS and RP-LC-ESI-MS glycomic profiles of permethylated N-glycans derived from model glycoproteins and human blood serum.
Hu Y; Mechref Y
Electrophoresis; 2012 Jul; 33(12):1768-77. PubMed ID: 22740465
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
[TBL] [Abstract][Full Text] [Related]
4. N-Glycomic Profiling of Pheochromocytomas and Paragangliomas Separates Metastatic and Nonmetastatic Disease.
Leijon H; Kaprio T; Heiskanen A; Satomaa T; Hiltunen JO; Miettinen MM; Arola J; Haglund C
J Clin Endocrinol Metab; 2017 Nov; 102(11):3990-4000. PubMed ID: 28938401
[TBL] [Abstract][Full Text] [Related]
5. N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.
Everest-Dass AV; Briggs MT; Kaur G; Oehler MK; Hoffmann P; Packer NH
Mol Cell Proteomics; 2016 Sep; 15(9):3003-16. PubMed ID: 27412689
[TBL] [Abstract][Full Text] [Related]
6. Quantifying Protein-Specific N-Glycome Profiles by Focused Protein and Immunoprecipitation Glycomics.
Kobayashi T; Ogawa K; Furukawa JI; Hanamatsu H; Hato M; Yoshinaga T; Morikawa K; Suda G; Sho T; Nakai M; Higashino K; Numata Y; Shinohara Y; Sakamoto N
J Proteome Res; 2019 Aug; 18(8):3133-3141. PubMed ID: 31266306
[TBL] [Abstract][Full Text] [Related]
7. Sensitive and robust MALDI-TOF-MS glycomics analysis enabled by Girard's reagent T on-target derivatization (GTOD) of reducing glycans.
Zhang Y; Wang B; Jin W; Wen Y; Nan L; Yang M; Liu R; Zhu Y; Wang C; Huang L; Song X; Wang Z
Anal Chim Acta; 2019 Feb; 1048():105-114. PubMed ID: 30598139
[TBL] [Abstract][Full Text] [Related]
8. Serum N-glycomic profiling may provide potential signatures for surveillance of COVID-19.
Xie Y; Butler M
Glycobiology; 2022 Sep; 32(10):871-885. PubMed ID: 35925863
[TBL] [Abstract][Full Text] [Related]
9. Comparative glycomic profiling of isotopically permethylated N-glycans by liquid chromatography/electrospray ionization mass spectrometry.
Hu Y; Desantos-Garcia JL; Mechref Y
Rapid Commun Mass Spectrom; 2013 Apr; 27(8):865-77. PubMed ID: 23495056
[TBL] [Abstract][Full Text] [Related]
10. Comparative glycomic profiling in esophageal adenocarcinoma.
Hammoud ZT; Mechref Y; Hussein A; Bekesova S; Zhang M; Kesler KA; Novotny MV
J Thorac Cardiovasc Surg; 2010 May; 139(5):1216-23. PubMed ID: 20412957
[TBL] [Abstract][Full Text] [Related]
11. MALDI-TOF MS/MS Analysis of Permethylated O-Glycan Alditols Released from Mucins.
Goso Y; Kurihara M
Methods Mol Biol; 2024; 2763():201-208. PubMed ID: 38347412
[TBL] [Abstract][Full Text] [Related]
12. Carbon Nanoparticles and Graphene Nanosheets as MALDI Matrices in Glycomics: a New Approach to Improve Glycan Profiling in Biological Samples.
Banazadeh A; Peng W; Veillon L; Mechref Y
J Am Soc Mass Spectrom; 2018 Sep; 29(9):1892-1900. PubMed ID: 29916086
[TBL] [Abstract][Full Text] [Related]
13. Glycomic Analysis of Life Stages of the Human Parasite Schistosoma mansoni Reveals Developmental Expression Profiles of Functional and Antigenic Glycan Motifs.
Smit CH; van Diepen A; Nguyen DL; Wuhrer M; Hoffmann KF; Deelder AM; Hokke CH
Mol Cell Proteomics; 2015 Jul; 14(7):1750-69. PubMed ID: 25883177
[TBL] [Abstract][Full Text] [Related]
14. In-Depth Analysis of the
Wang D; Kuzyk V; Madunić K; Zhang T; Mayboroda OA; Wuhrer M; Lageveen-Kammeijer GSM
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902272
[TBL] [Abstract][Full Text] [Related]
15. N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.
Alley WR; Vasseur JA; Goetz JA; Svoboda M; Mann BF; Matei DE; Menning N; Hussein A; Mechref Y; Novotny MV
J Proteome Res; 2012 Apr; 11(4):2282-300. PubMed ID: 22304416
[TBL] [Abstract][Full Text] [Related]
16. Dried blood spot N-glycome analysis by MALDI mass spectrometry.
Vreeker GCM; Bladergroen MR; Nicolardi S; Mesker WE; Tollenaar RAEM; van der Burgt YEM; Wuhrer M
Talanta; 2019 Dec; 205():120104. PubMed ID: 31450448
[TBL] [Abstract][Full Text] [Related]
17. CSF N-Glycomics Using MALDI MS Techniques in Alzheimer's Disease.
Palmigiano A; Messina A; Bua RO; Barone R; Sturiale L; Zappia M; Garozzo D
Methods Mol Biol; 2018; 1750():75-91. PubMed ID: 29512066
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
19. Towards automation of glycomic profiling of complex biological materials.
Shubhakar A; Pang PC; Fernandes DL; Dell A; Spencer DIR; Haslam SM
Glycoconj J; 2018 Jun; 35(3):311-321. PubMed ID: 29909447
[TBL] [Abstract][Full Text] [Related]
20. Complementary Glycomic Analyses of Sera Derived from Colorectal Cancer Patients by MALDI-TOF-MS and Microchip Electrophoresis.
Snyder CM; Alley WR; Campos MI; Svoboda M; Goetz JA; Vasseur JA; Jacobson SC; Novotny MV
Anal Chem; 2016 Oct; 88(19):9597-9605. PubMed ID: 27575585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
